Bookmark this pageiconPrint this pageE-mail this page

This is an international site for FEMARA® (letrozole) and is intended for Health Care Professionals outside the U.S. The information on the site is not country-specific, and may contain information that is outside the approved indications in the country in which you are located. Please contact your local Novartis representative for the latest information specific to your country.

Femara and Breast Cancer Information for International Healthcare Professionals Femara and Breast Cancer Information for US residents Femara and Breast Cancer Information for Patients Outside the US

Femara | Patient Case Study #1: Annette

FEMARA® patient case study #3: Annette

Clinical profile

Breast cancer characteristics

What do you think about Annette's case?

Please click on the most appropriate response.

1. Based on Annette's "low-risk" status, what is her risk for distant metastases?


2. If Annette developed distant metastases as a first recurrence, what is her risk of mortality within 5 years?


3. What treatment protocol would you use for Annette?